Precision oncology research increasingly hinges on integrated biomarker testing to refine targeted and immunotherapy development. Labcorp's comprehensive biomarker profiling platforms offer sample-sparing, high-throughput solutions that streamline complex clinical trials by harmonizing multi-modal data, facilitating patient stratification, and accelerating regulatory pathways. Effective biomarker integration reduces trial risks, improves therapy differentiation, and enhances return on investment in an environment driven by precision medicine. These advancements underscore the critical role of strategic biomarker workflows to optimize therapeutic development and regulatory success.